Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Ampulla of Vater Carcinoma
Adrenocortical Carcinoma
Neuroendocrine Carcinoma
Soft Tissue Sarcoma
Small Bowel Adenocarcinoma
Duodenum Adenocarcinoma
Gastric Adenocarcinoma

Interventions

DRUG: Dostarlimab
DRUG: Chemotherapy

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]